MEHMET A. AGIRBASLI, MD, FACC

Professor of Medicine & Cardiology
Medeniyet University Medical Center
Istanbul Turkey
e-mail 
magirbasli@gmail.com

Postdoctoral Training
Internal Medicine Residency:     March 1992 – March 1995
State University of New York at Buffalo    (Program Director: Robert Scheig, M.D.)
Cardiology Fellowship:    July 1995- June 98
Vanderbilt University
(Program Director: Douglas E. Vaughan, M.D.)
Advanced Fellowship:             July 98-June 99
(Interventional Cardiology)       Emory University
(Program Director: Spencer B. King III, M.D.)
Academic & Non-Academic Appointments
July 2015-Present           Professor of Cardiology
Medeniyet University Medical Center
Istanbul Turkey
October 2006- July 2015           Professor of Medicine & Cardiology

Marmara University Medical Center
Istanbul Turkey

 

PUBLICATIONS

  1. Aksoy A, Agirbasli M. High-sensitivity troponins and outcomes after myocardial infarction: the need for gender spesific cut off levels. J Am Coll Cardiol. 2018;72:1877.
  2. Agirbasli M. Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation. J Thromb Thrombolysis. 2018 Nov;46(4):570.
  3. Agirbasli D, Hyatt T, Agirbasli M. Familial hypercholesterolemia with extensive coronary artery disease and tuberous and tendinous xanthomas: A case report and mutation analysis. J Clin Lipidol. 2018;12:863-7.
  4. Avsar G, Agirbasli D, Agirbasli MA, Gunduz O, Oner ET. Levan based fibrous scaffolds electrospun via co-axial and single-needle techniques for tissue engineering applications. Carbohydr Polym. 2018 Aug 1;193:316-325.
  5. Agirbasli M. Impact of Residual Mitral Regurgitation on Right Ventricular Systolic Function After Left Ventricular Assist Device Implantation: Evidence for Populational Differences. Artif Organs. 2018 Jan;42(1):107.
  6. Ağırbaşlı M, Tanrıkulu A, Azizy M. Free estradiol index levels associated with high sensitivity CRP levels in male children.Turk J Pediatr. 2017;59(1):49-55.
  7. Agirbasli M. Influence of Diabetes on CABG Patency: Targeting Functional Status After CABG in Patients With DM. J Am Coll Cardiol. 2017 Nov 14;70(20):2604.
  8. Aslan A, Kartal Y, Ayaz E, Aslan M, Bulut SSD, Ağırbaşlı MA, Oysu AS. Bone Deformities as a Complication of Giant Thoracic Aortic Aneurysm. Vasc Endovascular Surg. 2017 Jul;51(5):312-315.
  9. Atas H, Sahin AA, Barutçu Atas D, Sunbul M, Kepez A, Agirbasli M. Potential Causes and Implications of Low Target Therapeutic Ratio in Warfarin-Treated Patients for Thrombosis Prophylaxis: A Single-Center Experience. Clin Appl Thromb Hemost. 2018 Apr;24(3):536-541.
  10. Agirbasli M, Göktay F, Peker I, Gunes P, Aker FV, Akkiprik M. Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions. Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12255.
  11. Tanrikulu MA, Agirbasli M, Berenson G. Primordial Prevention of Cardiometabolic Risk in Childhood. Adv Exp Med Biol. 2017;956:489-496. doi: 10.1007/5584_2016_172.
  12. Erginer M, Akcay A, Coskunkan B, Morova T, Rende D, Bucak S, Baysal N, Ozisik R, Eroglu MS, Agirbasli M, Toksoy Oner E. Sulfated levan from Halomonas smyrnensis as a bioactive, heparin-mimetic glycan for cardiac tissue engineering applications. Carbohydr Polym. 2016;149:289-96.
  13. Bulut EC, Abueid L, Ercan F, Süleymanoğlu S, Ağırbaşlı M, Yeğen BÇ. Treatment with oestrogen-receptor agonists or oxytocin in conjunction with exercise protects against post-menopausal myocardial infarction in rats. Exp Physiol. 2016 Mar 9. doi: 10.1113/EP085708.
  14. Ündar A, Wang S, Palanzo DA, Wise RK, Woitas K, Baer LD, Kunselman AR, Song J, Alkan-Bozkaya T, Akcevin A, Spencer S, Agirbasli M, Clark JB, Myers JL. Impact of Pulsatile Flow on Vital Organ Recovery During Cardiopulmonary Bypass in Neonates and Infants. Artif Organs. 2016 Jan;40(1):14-8. doi: 10.1111/aor.12632.
  15. Agirbasli M, Tanrikulu AM, Berenson GS. Metabolic Syndrome: Bridging the Gap from Childhood to Adulthood. Cardiovasc Ther. 2016 Feb;34(1):30-6. doi: 10.1111/1755-5922.12165.
  16. Sunbul M, Oguz M, Dogan Z, Atas H, Bozbay M, Cincin A, Agirbasli M. Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience. Clin Appl Thromb Hemost. 2015 Nov 12. pii: 1076029615614397. [Epub ahead of print]
  17. Sunbul M, Kivrak T, Durmus E, Akin H, Aydin Y, Ergelen R, Yilmaz Y, Agirbasli M. Non-alcoholic steatohepatitis score is an independent predictor of right ventricular dysfunction in patients with non-alcoholic fatty liver disease. Cardiovasc Ther. 2015 Jul 21. doi: 10.1111/1755-5922.12145.
  18. Agirbasli M, Tanrikulu A, Acar Sevim B, Azizy M, Bekiroglu N. Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children. Journal of Clinical Lipidology 2015;9(2):195-200.
  19. Sunbul M, Cagman Z, Gerin F, Ozgen Z, Durmus E, Seckin D, Ahmad S, Uras F, Agirbasli M. Growth Arrest-Specific 6 and Cardiometabolic Risk Factors in Patients with Psoriasis. Cardiovasc Ther. 2015; 33:56-61. doi: 10.1111/1755-5922.12112.
  20. White MJ, Eren F, Ağırbaşlı D, Chen J, Hu T, Moore JH, Williams SM, Ağırbaşlı M. A Systems Genetics Approach to Dyslipidemia in Children and Adolescents. OMICS. 2015;19:248-259. PMID: 25671407
  21. White MJ, Eren F, Agirbasli D, Williams SM, Agirbasli M. SHBG Gene Polymorphism (rs1799941) Associates with Metabolic Syndrome in Children and Adolescents. PLoS One. 2015 Feb 3;10(2):e0116915. doi: 10.1371/journal.pone.0116915. eCollection 2015.PMID: 25647406 [PubMed – in process]
  22. Agirbasli M, Tanrikulu A, Erkus E, Azizy M, Sevim BA, Kaya Z, Taskin A, Aksoy N, Demirbag R. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance. Acta Cardiol. 2014; 69(6):679-85.
  23. Aĝirbaşli M, Song J, Lei F, Wang S, Kunselman AR, Clark JB, Myers JL, Ündar A. Apolipoprotein e levels in pediatric patients undergoing cardiopulmonary bypass. Artif Organs. 2015; 39(1):28-33. doi: 10.1111/aor.12444. PMID: 25626577
  24. Sunbul M, Agirbasli M, Durmus E, Kivrak T, Akin H, Aydin Y, Ergelen R, Yilmaz Y. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. Atherosclerosis. 2014; 237(2):490-3. doi: 10.1016/j.atherosclerosis.2014.10.004. Epub 2014 Oct 17. PMID: 25463079 [PubMed – in process]
  25. Yasar Yildiz S, Kuru P, Toksoy Oner E, Agirbasli M.Functional stability of plasminogen activator inhibitor-1. ScientificWorldJournal. 2014;2014:858293. doi: 10.1155/2014/858293. Epub 2014 Oct 15.
  26. Hekim N, Coşkun Y, Sınav A, Abou-Zeid AH, Ağırbaşlı M, Akintola SO, Aynacıoğlu Ş, Bayram M, Bragazzi NL, Dandara C, Dereli T, Dove ES, Elbeyli L, Endrenyi L, Erciyas K, Faris J, Ferguson LR, Göğüş F, Güngör K, Gürsoy M, Gürsoy UK, Karaömerlioğlu MA, Kickbusch I, Kılıç T, Kılınç M, Kocagöz T, Lin B, LLerena A, Manolopoulos VG, Nair B, Özkan B, Pang T, Sardaş Ş, Srivastava S, Toraman C, Üstün K, Warnich L, Wonkam A, Yakıcıer MC, Yaşar Ü, Özdemir V. Translating biotechnology to knowledge-based innovation, peace, and development? Deploy a Science Peace Corps–an open letter to world leaders. 2014; 18(7):415-20. doi: 10.1089/omi.2014.0079.
  27. Sunbul M, Seckin D, Durmus E, Ozgen Z, Bozbay M, Bozbay A, Kivrak T, Oguz M, Sari I, Ergun T, Agirbasli M. Assessment of arterial stiffness and cardiovascular hemodynamics by oscillometric method in psoriasis patients with normal cardiac functions. Heart Vessels. 2014 Mar 15.PMID: 24633494 [Epub ahead of print]
  28. Dereli T, Coşkun Y, Kolker E, Güner O, Ağırbaşlı M, Ozdemir V. Big data and ethics review for health systems research in LMICs: understanding risk, uncertainty and ignorance and catching the black swans? Am J Bioeth. 2014;14(2):48-50. doi:10.1080/15265161.2013.
  29. Ündar A, Wang S, Palanzo D, Weaver B, Pekkan K, Agirbasli M, Zahn JD, Luciani GB, Clark JB, Wilson RP, Kunselman AR, Sano S, Belli E, Pierce WS, Myers JL. Outcomes of the ninth international conference on pediatric mechanical circulatory support systems and pediatric cardiopulmonary perfusion. Artif Organs. 2014 Jan;38(1):5-10. doi: 10.1111/aor.12213.
  30. Guney AI, Ergec D, Kirac D, Ozturhan H, Caner M, Koc G, Kaspar C, Ulucan K, Agirbasli M. Effects of ACE polymorphisms and other risk factors on the severity of coronary artery disease. Genet Mol Res. 2013 19;12(4):6895-906.
  31. Aĝirbaşli MA, Song J, Lei F, Wang S, Kunselman AR, Clark JB, Myers JL, Ündar A. Comparative effects of pulsatile and nonpulsatile flow on plasma fibrinolytic balance in pediatric patients undergoing cardiopulmonary bypass. Artif Organs. 2014 Jan;38(1):28-33. doi: 10.1111/aor.12182.
  32. Agirbasli M, Eren M, Yasar S, Delil K, Goktay F, Oner ET, Vaughan DE. Functionally stable plasminogen activator inhibitor-1 in a family with cardiovascular disease and vitiligo. J Thromb Thrombolysis. 2014; 38(1):50-6. doi: 10.1007/s11239-013-1021-x.PMID: 24197654
  33. Agirbasli M, Eren F, Agirbasli D, White MJ, Williams SM. Multi-locus candidate gene analyses of lipid levels in a pediatric Turkish cohort: lessons learned on LPL, CETP, LIPC, ABCA1, and SHBG. OMICS. 2013 Dec;17(12):636-45. doi: 10.1089/omi.2013.0066.
  34. Sunbul M, Eren F, Nacar C, Agirbasli M. Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women. Cardiol J. 2013;20(3):287-93. doi: 10.5603/CJ.2013.0074. PMID: 23788303
  35. Tanrıkulu A, Ağırbaşlı M. Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine. Anadolu Kardiyol Derg. 2013 Aug;13(5):486-94. doi: 10.5152/akd.2013.147. PMID: 23728227
  36. Sümerkan MÇ, Bulur S, Ağırbaşlı M. Unusual case with venous channels connecting the left and the right brachiocephalic veins. Anadolu Kardiyol Derg. 2013; 13(4):E21-2. PMID: 23618988
  37. Sunbul M, Agirbasli M. Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk? Curr Pharm Des. 2014; 20(4):529-35. PMID: 23565636
  38. Aĝirbaşli M, Ündar A. Monitoring biomarkers after pediatric heart surgery: a new paradigm on the horizon. Artif Organs. 2013; 37(1):10-5.
  39. Gunes FE, Bekiroglu N, Imeryuz N, Agirbasli M. Relation between eating habits and a high body mass index among freshman students: a cross-sectional study. J Am Coll Nutr 2012;31(3):167-74.
  40. Aksoy S, Cam N, Gurkan U, Oz D, Özden K, Altay S, Durmus G, Agirbasli M. Oxidative stress and severity of coronary artery disease in young smokers with acute myocardial infarction. Cardiol J. 2012;19(4):381-6.
  41. Ündar A, Alkan-Bozkaya T, Palanzo D, Ersayin-Kantas H, Chin C, Ödemiş E, Pekkan K, Ağirbaşli MA, Türköz A, Türköz R, Haydin S, Erek E, Yalçınbaş YK, Şaşmazel A, Karacı AR, Erkan H, Çicek AE, Bakır Í, Sarıoğlu T, Akçevin A, Aytaç A. Istanbul symposium on neonatal and pediatric cardiopulmonary bypass procedures. Artif Organs. 2012; 36(5):463-6.
  42. Aksoy S, Cam N, Gurkan U, Altay S, Bozbay M, Agirbasli M. Primary percutaneous intervention: for acute myocardial infarction in a patient with dextrocardia and situs inversus. Tex Heart Inst J. 2012;39(1):140-1.
  43. Aksoy S, Cam N, Guney MR, Gurkan U, Oz D, Poyraz E, Eksik A, Agirbasli M. Myocardial ischemia in severe aortic regurgitation despite angiographically normal coronary arteries. Tohoku J Exp Med. 2012;226(1):69-73.
  44. Undar A, Haydin S, Yivli P, Weaver B, Pauliks L, Cicek AE, Erek E, Saşmazel A, Ağirbaşli MA, Alkan-Bozkaya T, Akçevin A, Bakir I. Istanbul Symposiums on Pediatric Extracorporeal Life Support Systems. Artif Organs. 2011; 35:983-8.
  45. Coumbe A, John R, Kuskowski M, Agirbasli M, McFalls EO, Adabag S. Variation of mortality after coronary artery bypass surgery in relation to hour, day and month of the procedure. BMC Cardiovascular Disorders 2011,11:63 (doi:10.1186/1471-2261-11-63.
  46. Sumerkan MC, Agirbasli M, Altundag E, Bulur S. Mad-honey intoxication confirmed by pollen analysis. Clin Toxicol (Phila). 2011 PMID:21972794
  47. Agirbasli M, Agaoglu NB, Ergonul O, Yagmur I, Aydogar H, Oneri T, Ozturk O. Comparison of Anthropometric Indices in Predicting Metabolic Syndrome Components in Children. Metabolic Syndrome Related Disorders 2011;9:253-9.
  48. Agirbasli M, Adabag S, Ciliv G. Secular trends of blood pressure, body mass index, lipids and fasting glucose among children and adolescents in Turkey. Clin Obes. 2011; 1(4-6):161-7.
  49. Qiu F, Talor J, Zahn J, Pauliks L, Kunselman AR, Palanzo D, Baer L, Woitas K, Wise R, McCoach R, Weaver B, Carney E, Haines N, Uluer MC, Aran K, Sasso LA, Alkan-Bozkaya T, Akcevin A, Guan Y, Wang S, Agirbasli M, Clark JB, Myers JL, Undar A. Translational research in pediatric extracorporeal life support systems and cardiopulmonary bypass procedures: 2011 update. World J Pediatr Congenit Heart Surg. 2011; 2(3):476-81.
  50. Agirbasli D, Cirakoglu B, Eren F, Sumerkan M, Aksoy S, Aral C, Agirbasli M.Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels. J Clin Lipidol. 2011; 5(3):152-8.
  51. Agirbasli M, Guney AI, Ozturhan HS, Agirbasli D, Ulucan K, Sevinc D, Kirac D, Ryckman KK, Williams SM. Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1 and eNOS gene polymorphisms in patients with early onset coronary artery disease Eur J Cardiovasc Prev Rehabil 2011;18:803-9
  52. Agirbasli M, Eren M, Eren F, Murphy SB, Serdar ZA, Seckin D, Zara T, Cem Mat M, Demirkesen C, Vaughan DE. Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.J Thromb Thrombolysis. 2011;32:59-63
  53. Berenson GS, Agirbasli M, Nguyen QM, Chen W, Srinivasan SR. Glycemic status, metabolic syndrome, and cardiovascular risk in children.Med Clin North Am. 2011; 95(2):409-17
  54. Gümrükçüoğlu HA, Akyol A, Tuncer M, Güneş Y, Beğenik H, Akdağ S, Sahin M, Simşek H, Ağırbaşlı M. Clinical and laboratory features of patients with pericardial effusion, Turk Kardiyol Dern Ars. 2010;38(7):473-9. Turkish.
  55. Ağırbaşlı M, Güvenç H, Cinçin A. Novel agents in antiplatelet therapy, Turk Kardiyol Dern Ars. 2010 ;38(5):369-78. Review. Turkish.
  56. Agirbasli M, Sumerkan MC, Eren F, Agirbasli D. The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease. Heart Vessels. 2011;26(4):457-63.
  57. Aĝirbaşli M, Nguyen ML, Win K, Kunselman AR, Clark JB, Myers JL, Undar A. Inflammatory and hemostatic response to cardiopulmonary bypass in pediatric population: feasibility of seriological testing of multiple biomarkers.Artif Organs. 2010 Nov;34:987-95.
  58. Aksoy S, Gurkan U, Oz D, Dayi SU, Demirci D, Eksik A, Sayar N, Agirbasli M. The effects of blood pressure lowering on P-wave dispersion in patients with hypertensive crisis in emergency setting.Clin Exp Hypertens. 2010;32:486-9
  59. Agirbasli M, Agaoglu NB, Orak N, Caglioz H, Ocek T, Karabağ T, Baykan OA. Sex Hormones, Insulin Resistance and High-Density Lipoprotein Cholesterol Levels in Children Hormone Research 2010;73:166-174.
  60. Borici S, Agaoglu NB, Baykan OA, Agirbasli M Blood pressure and anthropometric measurements ın Albanian versus Turkish children and adolescents. Acta Cardiologica 2009;6:747-54.
  61. Ağirbaşli M. Slow coronary flow. Turk Kardiyol Dern Ars. 2009 Apr;37:174-6.
  62. Agirbasli M, Agaoglu NB, Orak N, Caglioz H, Ocek T, Poci N, Salaj A, Maya S. Sex hormones and metabolic syndrome in children and adolescents.Metabolism2009;58:1256-62
  63. Onat A, Hergenç G, Agırbaşlı M, Kaya Z, Can G, Unaltuna NE. Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking. Clin Chem Lab Med. 2009;47:208-215.
  64. Cincin AA, Ozben B, Tanrikulu MA, Baskan O, Agirbasli M. Large apical thrombus in a patient with persistent heart failure and hypereosinophilia: Löffler endocarditis. J Gen Intern Med. 2008;23:1713-8.
  65. Agirbasli M, Cincin A, Baykan OA.Short-term effects of angiotensin receptor blockers on blood pressure control, and plasma inflammatory and fibrinolytic parameters in patients taking angiotensin-converting enzyme inhibitors. J Renin Angiotensin Aldosterone Syst. 2008;9:22-6.
  66. Tanrikulu MA, Ozben B, Cincin AA, Baskan O, Agirbasli M. A pedunculated left ventricular hemangioma initially misdiagnosed as thrombus in a woman with atypical chest pain. J Thromb Thrombolysis. 2009;27:227-32.
  67. Agirbasli M, Baykan OA, Tekin A, Sengor F, Cincin AA, Demir M, Vaughan DE. Short term effects of GnRH agonists on plasma fibrinolytic balance in patients with advanced prostate cancer. J Thromb Thrombolysis. 2009;27:172-4.
  68. Agirbasli M, Papila-Topal N, Ogutmen B, Deniz H, Cakalagaoglu F, Tuglular S, Akoglu E. The blockade of the renin-angiotensin system reverses tacrolimus related cardiovascular toxicity at the histopathological level. J Renin Angiotensin Aldosterone Syst. 2007;8:54-8.
  69. Agirbasli M, Tanrikulu B, Arikan S, Izci E, Ozguven S, Besimoglu B, Ciliv G, Maradit-Kremers H. Trends in body mass index, blood pressure and parental smoking habits in middle socio-economic level Turkish adolescents. J Hum Hypertens. 2008;22:12-7.
  70. Ozkara C, Guler N, Batyraliev T, Okut H, Agirbasli M. Does off-pump coronary artery bypass surgery reduce secretion of plasminogen activator inhibitor-1? Int J Clin Pract. 2007;61(5):763-7.
  71. Agirbasli M; Inanc N; Baykan O; Direskeneli H. The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders Clinical and Experimental Rheumatology 2006;24:580-3.
  72. Agirbasli D, Agirbasli M, Williams SM, Phillips JA. Interaction among 5,10  methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the severity of coronary artery disease in Turkish patients. Coron Artery Dis. 2006;17:413-7.
  73. Agirbasli M, Cakir S, Ozme S, Ciliv G. Metabolic Syndrom in Turkish children and Metabolism. 2006;55:1002-6.
  74. Duman D, Demirtunc R, Duman D, Sungur F, Agirbasli M, Cakmak M. Paradoxical mesentery embolism and silent myocardial infarction in primary antiphospholipid syndrome: a case report. Heart Surg Forum. 2006;9:E592-4.
  75. Taymaz H, Erarslan S, Toksoy Öner E, Alkan T, Ağırbaşlı M, Kırdar B. Sequence variations within the genes related to hemostatic imbalance and their impact on coronary artery  disease in Turkish population. Thrombosis Research 2007;119:55-62.
  76. Guler N, Batyraliev T, Dulger H, Ozkara C, Tuncer M, Aslan S, Okut H, Agirbasli M.  The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting. Int J Cardiol. 2006;24;109:339-43.
  77. Agirbasli M, Ciliv G, Cakir S, Srinivasan S, Berenson GS, Ozme S. Body mass index and lipid levels in children from Ankara, Turkey versus Bogalusa, Louisiana. Prev Med 2005;4:843-5.
  78. Agirbasli M. Guler N. Recovery of left ventricular systolic function after left anterior        descending coronary artery stenting. Journal of Interventional Cardiology. 2005;18:83-8.
  79. Agirbasli M. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease.  International Journal of Clinical Practice. 2005;59:102-6.
  80. Guler N, Demirbag R, Ozkara C, Eryonucu B, Gunes A, Tuncer M, Guntekin U, Kocabas S, Agirbasli M. Clinical and echocardiographic predictors of left atrial appendage dysfunction in patients with mitral stenosis in sinus rhythm. J Am Soc Echocardiography 2004;17:819-23.
  81. Agirbasli MA, Fadel B. Aneurysm of the aorta-mitral continuity as a complication of aortic valve endocarditis. Echocardiography 1999;16:253-257.
  82. Agirbasli MA, Weintraub WS, Chang GL, King SB, Guyton RA, Thompson T, Alameddine F, Ghazzal ZMB. Outcome of coronary revascularization in patients on renal dialysis. American Journal of Cardiology 2000;86:395-399.
  83. Agirbasli MA, Morris DC, Marshall JJ. The use of  IntrastentTM peripheral stent in large coronary arteries: Report of three cases. Catheterization and Cardiovascular Diagnosis 2000;50:498-501.
  84. Agirbasli M, Hamid R, Tiller GE, Jennings HS. Situs Inversus with hypertrophic cardiomyopathy in identical twins. American Journal of Medical Genetics 2000;91:327-330.
  85. Brown NJ, Agirbasli M, Vaughan DE. Comparative effects of ACE inhibition and AT1 receptor antagonism on plasma fibrinolytic balance in humans. Hypertension 1999;34:285-290.
  86. Agirbasli MA, Vaughan DE. The renin-angiotensin system and vascular fibrinolytic balance. International Journal of Clinical Practice 1998;94(Supp):20-25.
  87. Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE. Angiotensin-converting enzyme inhibition decreases PAI-1 in the setting of an activated renin-angiotensin system. Hypertension 1998;32:965-971.
  88. Agirbasli MA, Hillegass WH, Chapman GD, Brott BC. Stent procedure complicated by thrombus formation within a muscle bridge distal to the lesion. Cathet Cardiovasc Diagnosis 1998;43:73-76.
  89. Agirbasli MA, Martin GS, Stout JB, Jennings HS, Lea JW, Dixon JH. Myocardial bridge as a cause of thrombus formation and myocardial infarction in a young athlete. Clinical Cardiology 1997;20:1032-1036.
  90. Misra VK, Agirbasli MA, Fischell TA. Coronary Artery Vasomotion after percutaneous transluminal coronary angioplasty. Clinical Cardiology 1997;20:915-922.
  91. Agirbasli MA, Hansen DE, Byrd BF. Resolution of vegetations with anticoagulation after myocardial infarction in primary m antiphospholipid syndrome. J Am Soc Echocardiography 1997;10:877-880.
  92. Agirbasli  MA, Radhakrishnamurthy B, Jiang X, Bao W, Berenson GS. Urinary N-Acetyl -β-D Glucosaminidase (NAG) changes in relation to age, sex, race, diastolic and systolic blood pressure in young adults.Am J Hypertension 1996;9:157-162.
  93. Agirbasli MA, Lenhardt MB, Arildsen RC, Myers PR. Coronary to pulmonary artery shunt via the bronchial artery demonstrated by magnetic resonance imaging (MRI). J Intervent Cardiology 1997;10:449-452.
  94. Kuru P, Ağırbaşlı M. Personalized and Participatory Medicine as a Future Tool Combat Cardiovascular Disease in Developing Countries. Current Pharmacogenomics and Personalized Medicine. 2014;12:133-140
  95. Agirbasli M, Bas-Bozkurtlar E, Papilla-Topal N, Deniz H, Ogutmen B, Cakalagaoglu F. Tacrolimus Toxicity Reverses the Inhibitory Effects of Renin Angiotensin System Blockade on PAI-1 Expression in Cardiac Tissue. Current Enzyme Inhibition 2013;9: 83-88.
  96. Ündar A, Bakır I, Haydin S,  Erek E,  Yivli P, Ödemiş E, Ağırbaşlı MA., Alkan-Bozkaya T, Türköz A, Türköz R, Şaşmazel A, Karacı AR, Çicek AE, Yalçınbaş YK., Akçevin A, Sarıoğlu T.  Congenital heart surgery in Turkey: Today and Tomorrow (Editorial-Turkish). Turkish J Thoracic Cardiovascular Surgery 2011;181-185. Türk Göğüs Kalp Damar Cerrahisi Dergisi 2012;20(2):181-185. (Turkish)
  97. Ündar A, Haydin S, Erek E,  Yivli P, Ödemiş E, Ağırbaşlı MA, Alkan-Bozkaya T, Türköz A, Türköz R, Şaşmazel A, Karacı AR, Çicek AE, Yalçınbaş YK, Akçevin A, Tayyar Sarıoğlu T , Bakır I.Recommendations For Techniques And Components’ Selection During Congenital Heart Surgery In Turkey. (Derleme). Türk Göğüs Kalp Damar Cerrahisi Dergisi 2012;20(2):399-405. (Turkish)
  98. Ağırbaşlı M. ST elevasyonlu miyokard enfarktüsünde GP IIb/IIIa reseptör inhibitörleriyle desteklenmiş trombolitik veya perkütan koroner girişim tedavisi. Türk Girişimsel Kardiyoloji Dergisi 2003;7(4):169-173 (Turkish)
  99. Ağırbaşlı M. ST elevasyonsuz miyokard enfarktüsü ve kararsız angina tedavisinde son gelişmeler. Türk Kardiyoloji Dergisi 2003;6(4):149-152 (Turkish)
  100. Agirbasli M. “Angiogenesis and Gene Therapy; Novel Concepts in Interventional  Cardiology” Seminars in Cardiology (In Turkish and English) 2002;2(3):248-256.
  101. Agirbasli M. “The use of GP IIb/IIIa inhibitors in acute coronary syndromes” Seminars in Cardiology (In Turkish and English) 2002(1):80-89.
  102. Agirbasli M. “The use of GP IIb/IIIa inhibitors in after percutaneous coronary interventions” Turkish Journal of  Invasive Cardiology 2001(Supplement):49-54.
  103. Ağırbaşlı M. The renin angiotensin system and vascular fibrinolytic balance.                                             Turk J Haematol 2000;17(3):152-158.
  104. Ağırbaşlı M. Platelet glycoprotein IIb/IIIa receptor inhibitors in cardiology. Turk J Haematol 2000;17(3):143-151.
  105. Agirbasli MA, Vaughan DE. The role of renin angiotensin system in regulating fibrinolytic balance: Potential mechanism in preventing myocardial infarction. Turkish J Medical Sciences 1999;29:1-7.
  106. Agirbasli MA, King SB. New frontiers in the reperfusion of myocardial infarction. Turkish J Medical Sciences 1999;28:1-6.
  107. Agirbasli MA, Kerins DM. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: A new paradigm in cardiology. Turkish J Medical Sciences 1998;28:209-218.
  108. Agirbasli MA, Graham SP. Peri-partum cardiomyopathy fifteen years after doxorubicin therapy. Turkish J Medical Sciences 1997;27:183-184.